Hereditary and Acquired Antithrombin Deficiency
- 1 January 2007
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 67 (10) , 1429-1440
Abstract
Antithrombin is a glycoprotein critical to the regulation of coagulation. Its primary action is the inhibition of the activated coagulation factors IIa (thrombin) and Xa. In addition there is growing...Keywords
This publication has 78 references indexed in Scilit:
- Management of thrombophiliaJournal of Thrombosis and Haemostasis, 2003
- Relationship between coagulation cascade, cytokine, adhesion molecule and aortic aneurysmEuropean Journal of Cardio-Thoracic Surgery, 2003
- Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l-asparaginase for acute lymphoblastic leukemiaThrombosis and Haemostasis, 2003
- The incidence of venous thromboembolism in thrombophilic children: a prospective cohort studyBlood, 2002
- ANTITHROMBIN III SUPPLEMENTATION IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH L-ASPARAGINASEPediatric Hematology and Oncology, 2002
- Antithrombin-III for the treatment of chemotherapy-induced organ dysfunction following bone marrow transplantationBone Marrow Transplantation, 1997
- Increased fetal loss in women with heritable thrombophiliaThe Lancet, 1996
- Clotting inhibitors and fibronectin as potential markers in preeclampsiaInternational Journal of Gynecology & Obstetrics, 1994
- Influence of demographic factors on antithrombin III activity in a healthy populationBritish Journal of Haematology, 1993
- A surprising new protein superfamily containing ovalbumin, antithrombin-III, and alpha1-proteinase inhibitorBiochemical and Biophysical Research Communications, 1980